KalshiVerificar disponibilidadeKYC obrigatório2% de taxaDados de resolução verificadosRazoavelmente calibradoProbabilidade implícita atual
Before 2028 72%Líder entre 3 opções
Qualidade do mercado
46 / 100
Baixa qualidadeVolume 24h
451,8 €
Liquidez
2,1 mil €
Baixa liquidezSpread
6.0 pt
Spread amploDados do mercado
Atualizado há 10 minutos
24/03/26, 14:00 UTC1/07/27, 03:59 UTC
Tendências
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
When will Intellia Therapeutics submit a BLA for Lonvo-z?
KalshiWill the FDA approve retatrutide?
KalshiWill the FDA approve any psychedelic substance for medical use this year?
KalshiWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
Manifold MarketsRegras
If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.
- If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Oct 1, 2027, then the market resolves to Yes.
- If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.
Mercados abertos
Health & Medicine
POLYMARKETEbola pandemic in 2026?
- No+1.1pt97%
- Yes-1.1pt3%
- Volume total
- € 650,1 mil
- Volume 24h
- € 29,7 mil
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume total
- € 15,6 mi
- Volume 24h
- € 20,5 mil
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volume total
- € 1,6 mi
- Volume 24h
- € 5,2 mil
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt64%
- September+2.0pt41%
- June28%
- Volume total
POLYMARKETNew pandemic in 2026?
- No93.1%
- Yes6.9%
- Volume total
- € 915,1 mil
- Volume 24h
- € 3,2 mil
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before 2027+8.0pt84%
- before April 202781%
- before December+1.0pt69%
+3 mais resultados
- Volume total
- € 14,2 mil
- Measles cases in 2026?
- New pandemic before 2028?
- Ebola pandemic in 2026?
- Will the FDA approve any psychedelic substance for medical use this year?
- Measles cases in U.S. in 2026?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA approves Retatrutide this year?
- Which countries will report an Ebola case in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- How many human screwworm cases will be reported in the United States in 2026?
Perguntas frequentes
- Quais são as probabilidades atuais de When will the FDA approve Intellia Therapeutics' lonvo-z??
- A Kalshi cota Before 2028 em 72% em 8 de setembro de 2026.
- Quando When will the FDA approve Intellia Therapeutics' lonvo-z? é resolvido?
- When will the FDA approve Intellia Therapeutics' lonvo-z? deverá ser resolvido em 1 de julho de 2027.
- Como When will the FDA approve Intellia Therapeutics' lonvo-z? é liquidado?
- A Kalshi liquida este mercado da seguinte forma: If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.